Mojisola Adeyeye
Mojisola Adeyeye is a renowned pharmacologist and the current Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria. She is recognized for her significant contributions to the field of pharmacology and her efforts to ensure the safety and efficacy of drugs in Nigeria.
Early Life and Education[edit]
Mojisola Adeyeye was born in Nigeria. She completed her Bachelor's degree in Pharmaceutics from the University of Nigeria, Nsukka. She then pursued her Master's degree in Pharmaceutics from the University of Georgia, Athens, USA. She further obtained her Ph.D. in Pharmaceutics from the University of Nigeria, Nsukka.
Career[edit]
Adeyeye began her career as a pharmacist in Nigeria. She later moved to the United States, where she worked as a professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois.
In November 2017, she was appointed as the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria. In this role, she has been instrumental in implementing stringent measures to ensure the safety and efficacy of drugs in the country.
Contributions to Pharmacology[edit]
Adeyeye has made significant contributions to the field of pharmacology. She has conducted extensive research in the areas of drug delivery systems and nanotechnology. Her work has led to the development of innovative drug delivery systems, which have significantly improved the efficacy of drugs.
She has also been involved in the development of regulatory policies for drugs in Nigeria. Her efforts have led to the implementation of stringent measures to ensure the safety and efficacy of drugs in the country.
Awards and Recognition[edit]
Adeyeye has received numerous awards and recognition for her contributions to the field of pharmacology. She was awarded the International Pharmaceutical Federation (FIP) Fellowship in 2017 for her significant contributions to the field of pharmacy and pharmaceutical sciences.
See Also[edit]
- Pharmacology
- National Agency for Food and Drug Administration and Control
- Drug delivery system
- Nanotechnology
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
